11
|
Phi XA, Houssami N, Obdeijn IM, Warner E, Sardanelli F, Leach MO, Riedl CC, Trop I, Tilanus-Linthorst MMA, Mandel R, Santoro F, Kwan-Lim G, Helbich TH, de Koning HJ, Van den Heuvel ER, de Bock GH. Magnetic resonance imaging improves breast screening sensitivity in BRCA mutation carriers age ≥ 50 years: evidence from an individual patient data meta-analysis. J Clin Oncol 2015; 33:349-56. [PMID: 25534390 DOI: 10.1200/jco.2014.56.6232] [Citation(s) in RCA: 55] [Impact Index Per Article: 6.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022] Open
Abstract
PURPOSE There is no consensus on whether magnetic resonance imaging (MRI) should be included in breast screening protocols for women with BRCA1/2 mutations age ≥ 50 years. Therefore, we investigated the evidence on age-related screening accuracy in women with BRCA1/2 mutations using individual patient data (IPD) meta-analysis. PATIENTS AND METHODS IPD were pooled from six high-risk screening trials including women with BRCA1/2 mutations who had completed at least one screening round with both MRI and mammography. A generalized linear mixed model with repeated measurements and a random effect of studies estimated sensitivity and specificity of MRI, mammography, and the combination in all women and specifically in those age ≥ 50 years. RESULTS Pooled analysis showed that in women age ≥ 50 years, screening sensitivity was not different from that in women age < 50 years, whereas screening specificity was. In women age ≥ 50 years, combining MRI and mammography significantly increased screening sensitivity compared with mammography alone (94.1%; 95% CI, 77.7% to 98.7% v 38.1%; 95% CI, 22.4% to 56.7%; P < .001). The combination was not significantly more sensitive than MRI alone (94.1%; 95% CI, 77.7% to 98.7% v 84.4%; 95% CI, 61.8% to 94.8%; P = .28). Combining MRI and mammography in women age ≥ 50 years resulted in sensitivity similar to that in women age < 50 years (94.1%; 95% CI, 77.7% to 98.7% v 93.2%; 95% CI, 79.3% to 98%; P = .79). CONCLUSION Addition of MRI to mammography for screening BRCA1/2 mutation carriers age ≥ 50 years improves screening sensitivity by a magnitude similar to that observed in younger women. Limiting screening MRI in BRCA1/2 carriers age ≥ 50 years should be reconsidered.
Collapse
Affiliation(s)
- Xuan-Anh Phi
- Xuan-Anh Phi, Edwin R. Van den Heuvel, and Geertruida H. de Bock, University of Groningen, University Medical Center Groningen, Groningen; Inge-Marie Obdeijn, Madeleine M.A. Tilanus-Linthorst, and Harry J. de Koning, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands; Nehmat Houssami, School of Public Health, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia; Ellen Warner and Rodica Mandel, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario; Isabelle Trop, Hospital of Montreal, Montreal, Quebec, Canada; Francesco Sardanelli, University of Milan School of Medicine, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Donato, Milan; Filippo Santoro, Istituto Superiore di Sanità, Rome, Italy; Martin O. Leach and Gek Kwan-Lim, Institute of Cancer Research and Royal Marsden National Health Service Foundation Trust, London, United Kingdom; and Christopher C. Riedl and Thomas H. Helbich, Medical University Vienna, Vienna, Austria
| | - Nehmat Houssami
- Xuan-Anh Phi, Edwin R. Van den Heuvel, and Geertruida H. de Bock, University of Groningen, University Medical Center Groningen, Groningen; Inge-Marie Obdeijn, Madeleine M.A. Tilanus-Linthorst, and Harry J. de Koning, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands; Nehmat Houssami, School of Public Health, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia; Ellen Warner and Rodica Mandel, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario; Isabelle Trop, Hospital of Montreal, Montreal, Quebec, Canada; Francesco Sardanelli, University of Milan School of Medicine, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Donato, Milan; Filippo Santoro, Istituto Superiore di Sanità, Rome, Italy; Martin O. Leach and Gek Kwan-Lim, Institute of Cancer Research and Royal Marsden National Health Service Foundation Trust, London, United Kingdom; and Christopher C. Riedl and Thomas H. Helbich, Medical University Vienna, Vienna, Austria
| | - Inge-Marie Obdeijn
- Xuan-Anh Phi, Edwin R. Van den Heuvel, and Geertruida H. de Bock, University of Groningen, University Medical Center Groningen, Groningen; Inge-Marie Obdeijn, Madeleine M.A. Tilanus-Linthorst, and Harry J. de Koning, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands; Nehmat Houssami, School of Public Health, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia; Ellen Warner and Rodica Mandel, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario; Isabelle Trop, Hospital of Montreal, Montreal, Quebec, Canada; Francesco Sardanelli, University of Milan School of Medicine, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Donato, Milan; Filippo Santoro, Istituto Superiore di Sanità, Rome, Italy; Martin O. Leach and Gek Kwan-Lim, Institute of Cancer Research and Royal Marsden National Health Service Foundation Trust, London, United Kingdom; and Christopher C. Riedl and Thomas H. Helbich, Medical University Vienna, Vienna, Austria
| | - Ellen Warner
- Xuan-Anh Phi, Edwin R. Van den Heuvel, and Geertruida H. de Bock, University of Groningen, University Medical Center Groningen, Groningen; Inge-Marie Obdeijn, Madeleine M.A. Tilanus-Linthorst, and Harry J. de Koning, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands; Nehmat Houssami, School of Public Health, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia; Ellen Warner and Rodica Mandel, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario; Isabelle Trop, Hospital of Montreal, Montreal, Quebec, Canada; Francesco Sardanelli, University of Milan School of Medicine, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Donato, Milan; Filippo Santoro, Istituto Superiore di Sanità, Rome, Italy; Martin O. Leach and Gek Kwan-Lim, Institute of Cancer Research and Royal Marsden National Health Service Foundation Trust, London, United Kingdom; and Christopher C. Riedl and Thomas H. Helbich, Medical University Vienna, Vienna, Austria
| | - Francesco Sardanelli
- Xuan-Anh Phi, Edwin R. Van den Heuvel, and Geertruida H. de Bock, University of Groningen, University Medical Center Groningen, Groningen; Inge-Marie Obdeijn, Madeleine M.A. Tilanus-Linthorst, and Harry J. de Koning, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands; Nehmat Houssami, School of Public Health, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia; Ellen Warner and Rodica Mandel, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario; Isabelle Trop, Hospital of Montreal, Montreal, Quebec, Canada; Francesco Sardanelli, University of Milan School of Medicine, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Donato, Milan; Filippo Santoro, Istituto Superiore di Sanità, Rome, Italy; Martin O. Leach and Gek Kwan-Lim, Institute of Cancer Research and Royal Marsden National Health Service Foundation Trust, London, United Kingdom; and Christopher C. Riedl and Thomas H. Helbich, Medical University Vienna, Vienna, Austria
| | - Martin O Leach
- Xuan-Anh Phi, Edwin R. Van den Heuvel, and Geertruida H. de Bock, University of Groningen, University Medical Center Groningen, Groningen; Inge-Marie Obdeijn, Madeleine M.A. Tilanus-Linthorst, and Harry J. de Koning, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands; Nehmat Houssami, School of Public Health, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia; Ellen Warner and Rodica Mandel, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario; Isabelle Trop, Hospital of Montreal, Montreal, Quebec, Canada; Francesco Sardanelli, University of Milan School of Medicine, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Donato, Milan; Filippo Santoro, Istituto Superiore di Sanità, Rome, Italy; Martin O. Leach and Gek Kwan-Lim, Institute of Cancer Research and Royal Marsden National Health Service Foundation Trust, London, United Kingdom; and Christopher C. Riedl and Thomas H. Helbich, Medical University Vienna, Vienna, Austria
| | - Christopher C Riedl
- Xuan-Anh Phi, Edwin R. Van den Heuvel, and Geertruida H. de Bock, University of Groningen, University Medical Center Groningen, Groningen; Inge-Marie Obdeijn, Madeleine M.A. Tilanus-Linthorst, and Harry J. de Koning, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands; Nehmat Houssami, School of Public Health, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia; Ellen Warner and Rodica Mandel, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario; Isabelle Trop, Hospital of Montreal, Montreal, Quebec, Canada; Francesco Sardanelli, University of Milan School of Medicine, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Donato, Milan; Filippo Santoro, Istituto Superiore di Sanità, Rome, Italy; Martin O. Leach and Gek Kwan-Lim, Institute of Cancer Research and Royal Marsden National Health Service Foundation Trust, London, United Kingdom; and Christopher C. Riedl and Thomas H. Helbich, Medical University Vienna, Vienna, Austria
| | - Isabelle Trop
- Xuan-Anh Phi, Edwin R. Van den Heuvel, and Geertruida H. de Bock, University of Groningen, University Medical Center Groningen, Groningen; Inge-Marie Obdeijn, Madeleine M.A. Tilanus-Linthorst, and Harry J. de Koning, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands; Nehmat Houssami, School of Public Health, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia; Ellen Warner and Rodica Mandel, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario; Isabelle Trop, Hospital of Montreal, Montreal, Quebec, Canada; Francesco Sardanelli, University of Milan School of Medicine, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Donato, Milan; Filippo Santoro, Istituto Superiore di Sanità, Rome, Italy; Martin O. Leach and Gek Kwan-Lim, Institute of Cancer Research and Royal Marsden National Health Service Foundation Trust, London, United Kingdom; and Christopher C. Riedl and Thomas H. Helbich, Medical University Vienna, Vienna, Austria
| | - Madeleine M A Tilanus-Linthorst
- Xuan-Anh Phi, Edwin R. Van den Heuvel, and Geertruida H. de Bock, University of Groningen, University Medical Center Groningen, Groningen; Inge-Marie Obdeijn, Madeleine M.A. Tilanus-Linthorst, and Harry J. de Koning, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands; Nehmat Houssami, School of Public Health, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia; Ellen Warner and Rodica Mandel, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario; Isabelle Trop, Hospital of Montreal, Montreal, Quebec, Canada; Francesco Sardanelli, University of Milan School of Medicine, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Donato, Milan; Filippo Santoro, Istituto Superiore di Sanità, Rome, Italy; Martin O. Leach and Gek Kwan-Lim, Institute of Cancer Research and Royal Marsden National Health Service Foundation Trust, London, United Kingdom; and Christopher C. Riedl and Thomas H. Helbich, Medical University Vienna, Vienna, Austria
| | - Rodica Mandel
- Xuan-Anh Phi, Edwin R. Van den Heuvel, and Geertruida H. de Bock, University of Groningen, University Medical Center Groningen, Groningen; Inge-Marie Obdeijn, Madeleine M.A. Tilanus-Linthorst, and Harry J. de Koning, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands; Nehmat Houssami, School of Public Health, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia; Ellen Warner and Rodica Mandel, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario; Isabelle Trop, Hospital of Montreal, Montreal, Quebec, Canada; Francesco Sardanelli, University of Milan School of Medicine, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Donato, Milan; Filippo Santoro, Istituto Superiore di Sanità, Rome, Italy; Martin O. Leach and Gek Kwan-Lim, Institute of Cancer Research and Royal Marsden National Health Service Foundation Trust, London, United Kingdom; and Christopher C. Riedl and Thomas H. Helbich, Medical University Vienna, Vienna, Austria
| | - Filippo Santoro
- Xuan-Anh Phi, Edwin R. Van den Heuvel, and Geertruida H. de Bock, University of Groningen, University Medical Center Groningen, Groningen; Inge-Marie Obdeijn, Madeleine M.A. Tilanus-Linthorst, and Harry J. de Koning, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands; Nehmat Houssami, School of Public Health, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia; Ellen Warner and Rodica Mandel, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario; Isabelle Trop, Hospital of Montreal, Montreal, Quebec, Canada; Francesco Sardanelli, University of Milan School of Medicine, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Donato, Milan; Filippo Santoro, Istituto Superiore di Sanità, Rome, Italy; Martin O. Leach and Gek Kwan-Lim, Institute of Cancer Research and Royal Marsden National Health Service Foundation Trust, London, United Kingdom; and Christopher C. Riedl and Thomas H. Helbich, Medical University Vienna, Vienna, Austria
| | - Gek Kwan-Lim
- Xuan-Anh Phi, Edwin R. Van den Heuvel, and Geertruida H. de Bock, University of Groningen, University Medical Center Groningen, Groningen; Inge-Marie Obdeijn, Madeleine M.A. Tilanus-Linthorst, and Harry J. de Koning, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands; Nehmat Houssami, School of Public Health, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia; Ellen Warner and Rodica Mandel, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario; Isabelle Trop, Hospital of Montreal, Montreal, Quebec, Canada; Francesco Sardanelli, University of Milan School of Medicine, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Donato, Milan; Filippo Santoro, Istituto Superiore di Sanità, Rome, Italy; Martin O. Leach and Gek Kwan-Lim, Institute of Cancer Research and Royal Marsden National Health Service Foundation Trust, London, United Kingdom; and Christopher C. Riedl and Thomas H. Helbich, Medical University Vienna, Vienna, Austria
| | - Thomas H Helbich
- Xuan-Anh Phi, Edwin R. Van den Heuvel, and Geertruida H. de Bock, University of Groningen, University Medical Center Groningen, Groningen; Inge-Marie Obdeijn, Madeleine M.A. Tilanus-Linthorst, and Harry J. de Koning, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands; Nehmat Houssami, School of Public Health, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia; Ellen Warner and Rodica Mandel, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario; Isabelle Trop, Hospital of Montreal, Montreal, Quebec, Canada; Francesco Sardanelli, University of Milan School of Medicine, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Donato, Milan; Filippo Santoro, Istituto Superiore di Sanità, Rome, Italy; Martin O. Leach and Gek Kwan-Lim, Institute of Cancer Research and Royal Marsden National Health Service Foundation Trust, London, United Kingdom; and Christopher C. Riedl and Thomas H. Helbich, Medical University Vienna, Vienna, Austria
| | - Harry J de Koning
- Xuan-Anh Phi, Edwin R. Van den Heuvel, and Geertruida H. de Bock, University of Groningen, University Medical Center Groningen, Groningen; Inge-Marie Obdeijn, Madeleine M.A. Tilanus-Linthorst, and Harry J. de Koning, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands; Nehmat Houssami, School of Public Health, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia; Ellen Warner and Rodica Mandel, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario; Isabelle Trop, Hospital of Montreal, Montreal, Quebec, Canada; Francesco Sardanelli, University of Milan School of Medicine, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Donato, Milan; Filippo Santoro, Istituto Superiore di Sanità, Rome, Italy; Martin O. Leach and Gek Kwan-Lim, Institute of Cancer Research and Royal Marsden National Health Service Foundation Trust, London, United Kingdom; and Christopher C. Riedl and Thomas H. Helbich, Medical University Vienna, Vienna, Austria
| | - Edwin R Van den Heuvel
- Xuan-Anh Phi, Edwin R. Van den Heuvel, and Geertruida H. de Bock, University of Groningen, University Medical Center Groningen, Groningen; Inge-Marie Obdeijn, Madeleine M.A. Tilanus-Linthorst, and Harry J. de Koning, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands; Nehmat Houssami, School of Public Health, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia; Ellen Warner and Rodica Mandel, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario; Isabelle Trop, Hospital of Montreal, Montreal, Quebec, Canada; Francesco Sardanelli, University of Milan School of Medicine, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Donato, Milan; Filippo Santoro, Istituto Superiore di Sanità, Rome, Italy; Martin O. Leach and Gek Kwan-Lim, Institute of Cancer Research and Royal Marsden National Health Service Foundation Trust, London, United Kingdom; and Christopher C. Riedl and Thomas H. Helbich, Medical University Vienna, Vienna, Austria
| | - Geertruida H de Bock
- Xuan-Anh Phi, Edwin R. Van den Heuvel, and Geertruida H. de Bock, University of Groningen, University Medical Center Groningen, Groningen; Inge-Marie Obdeijn, Madeleine M.A. Tilanus-Linthorst, and Harry J. de Koning, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands; Nehmat Houssami, School of Public Health, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia; Ellen Warner and Rodica Mandel, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario; Isabelle Trop, Hospital of Montreal, Montreal, Quebec, Canada; Francesco Sardanelli, University of Milan School of Medicine, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Donato, Milan; Filippo Santoro, Istituto Superiore di Sanità, Rome, Italy; Martin O. Leach and Gek Kwan-Lim, Institute of Cancer Research and Royal Marsden National Health Service Foundation Trust, London, United Kingdom; and Christopher C. Riedl and Thomas H. Helbich, Medical University Vienna, Vienna, Austria.
| |
Collapse
|